Improving Human Papillomavirus (HPV) Vaccine Rates Using Evidence-Based Communication Strategies for Provider Education
Loading...
Date
2019-05
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
The Ohio State University
Abstract
Abstract
Introduction: Human Papillomavirus (HPV) causes 32,500 new cancers and roughly 14 million new infections annually in the United States. These cancers include cervical, oropharyngeal, anal, vaginal, vulvar, penile cancers and genital warts (Centers for Disease Control and Prevention (CDC), 2015). While the HPV vaccine was approved in 2006, HPV vaccination rates are not progressing as planned toward the Healthy People 2020 goal of 80% coverage, with Ohio rates in the 50-59% range.
Purpose: The purpose of this project is to identify HPV immunization initiation rates and to implement a communication strategy to improve rates for adolescent patients.
Methods: This DNP project pilot tested an evidence-based provider communication intervention with goal of improving HPV vaccination rates in an adolescent population, 11-18 years of age. Impact of the educational intervention was evaluated by comparing pre-intervention and post-intervention HPV vaccination rates in a Midwest pediatric primary care practice.
Results: A total of 1024 total patient records identified both pre-intervention and post-intervention that met inclusion criteria. Between the four providers, the total patient counts ranged from 108 to 610. Pre-intervention vaccination rates ranged from 44.43% to 59.30%. Post-intervention vaccination rates ranged from 47.86% to 62.78%. The change in satisfaction increased across all providers ranging from 3.71% to 8.60%
Conclusions: The intervention was found to be a cost-effective and time-sensitive intervention to promote improved HPV vaccination rates. Overall, the average rate increased from 49.31% to 53.01%